Delivery Order SPE2DB20D3101-SPE2DB24FRPR6

Award Date 7/10/24
Potential Completion Date 7/31/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $21,077.60 to the Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of Tagrisso 80 mg tablets, a prescription medication. This Delivery Order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $10,662.57 delivery order contract is for the supply of the pharmaceutical product Tagrisso 80 mg tablet 30s. The contract is a firm fixed-price, non-set-aside award with a completion date of June 11, 2025. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,662.57 firm fixed-price contract is for the delivery of the prescription medication Tagrisso 80 mg tablets. The contract has an ultimate completion date of May 12, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $42,607.28 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tagrisso 80 mg tablets, a cancer medication, with a period of performance through July 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $10,662.57 delivery order contract is for the medication TAGRISSO 80 MG TABLET 30S. The contract is a firm fixed-price, non-set-aside award with a completion date of July 3, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tagrisso 80 mg tablets, with a ceiling value of $10,662.57 and a performance period through July 3, 2025. The contract is not set aside and is awarded as an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of pharmaceutical products. The $10,247.06 firm fixed-price contract is for the delivery of Tagrisso 80 mg tablets. The contract has an ultimate completion date of July 26, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,662.57 firm fixed-price delivery order is for the supply of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 1, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,903.03, is for the delivery of the prescription medication Tagrisso 80 mg tablets. It is a firm fixed-price delivery order contract with a completion date of December 16, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $10,641.07, is for the delivery of the prescription medication Tagrisso 40 mg tablets. The contract is a Firm Fixed Price Delivery Order, with a performance period through May 8, 2025. This award is not associated with a set-aside program and represents open competition....
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRPR6
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $10,538.79 to Amerisourcebergen Drug Corporation for the supply of Tagrisso 80 mg tablets. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials like syringes and test kits, to support the logistics and medical needs of the U.S. Department of Defense worldwide. The contract has no set-aside designation.

Generated 10/9/24, 9:11 AM